查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1575010

植體周圍炎治療市場，按產品類型、治療類型、作用機制、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Peri-Implantitis Treatment Market, By Product Type, By Treatment Type, By Mechanism of Action, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年，植體周圍炎治療市場規模為24.8043億美元，2024年至2032年複合年成長率為8.90%。

植體周圍炎治療市場-市場動態

老年人口的增加刺激了植體周圍炎治療市場的需求

老年人口的增加大大增加了植體周圍炎治療市場的需求，因為老年人更容易出現牙科併發症，包括植體失敗。據世界衛生組織稱，到 2050 年，全球 60 歲及以上人口預計將達到 20 億，這導致對有效牙科護理解決方案的需求不斷增加。此外，研究顯示植體周圍炎影響近 10-20% 的植體患者，這凸顯了針對性治療的必要性。美國牙周病學會等組織的措施重點是對醫療保健專業人員進行預防和治療選擇方面的教育，進一步推動市場成長。隨著人們認知的不斷提高和先進治療方法的採用，植體周圍炎治療領域已做好充分準備，可以滿足人口老齡化人口不斷變化的需求，突顯人口趨勢和醫療保健創新的關鍵交叉點。

植體周圍炎治療市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 8.90% 左右的複合年成長率成長

根據產品類型細分，預計抗生素將在 2023 年佔據最大市場佔有率

根據治療類型細分，非手術治療是 2023 年的主導類型

基於行動機制細分，在地化交付是2023年的主導類型

按地區分類，北美是 2023 年的主要收入來源

植體周圍炎治療市場-細分分析：

全球植體周圍炎治療市場根據產品類型、治療類型、作用機制、最終用戶和地區進行細分。

根據產品類型，市場分為四大類：抗生素、防腐劑、骨移植和再生材料。抗生素因其在控制感染方面的有效性而優先考慮，其次是有助於減少微生物負荷的防腐劑。骨移植在恢復骨骼完整性方面發揮著至關重要的作用，而再生材料則支持組織癒合和再生。

根據治療類型，市場分為兩類：非手術治療和手術治療。非手術治療因其微創性和早期有效性而被優先考慮，而手術治療對於需要更廣泛干預以恢復植體健康和功能的晚期病例至關重要。

植體周圍炎治療市場 - 地理洞察

植體周圍炎治療市場呈現出顯著的地區差異，北美因其先進的醫療基礎設施和牙種植體的高採用率而成為領先地區。美國牙科協會強調，美國有近 300 萬人植牙，增加了植體周圍炎治療的需求。歐洲緊隨其後，德國和英國等國家投資先進的牙科技術和旨在改善植牙效果的研究計畫。在亞太地區，快速的城市化和可支配收入的增加正在推動對牙種植體和相關治療的需求，泰國和印度等國家的牙科旅遊業顯著增加。同時，中東和非洲地區的牙科保健意識和可近性逐漸提高，措施的重點是改善醫療基礎設施。隨著全球合作和研究的擴大，植體周圍炎的治療格局必將持續發展，解決不同地區面臨的獨特挑戰，同時在全球範圍內促進更好的口腔健康實踐。

植體周圍炎治療市場-競爭格局：

在植體周圍炎治療市場的競爭格局中，在 Zimmer Biomet 和 Dentsply Sirona 等處於創新治療解決方案前沿的主要參與者的推動下，北美脫穎而出，成為主導地區。美國牙周病學會報告稱，大約 10% 至 20% 的植牙患者患有植體周圍炎，這刺激了先進療法的發展。歐洲緊隨其後，Straumann 和 BioHorizo​​​​ns 等公司在嚴格的臨床研究的支持下處於領先地位，以提高治療效果。在亞太地區，人們對口腔健康的認知不斷增強，植牙採用率不斷提高，正在促進市場成長，Osstem Implant 等區域企業也越來越受到關注。中東和非洲的牙科醫療保健投資不斷增加，當地措施的重點是改善獲得優質植體周圍炎治療的機會。總體而言，競爭格局的特點是既有老牌企業，也有新興公司，它們都在努力滿足全球範圍內對有效植體周圍炎管理解決方案日益成長的需求。

最新進展：

2023 年 11 月，加州大學洛杉磯分校的研究人員開發了一種突破性的紫外線技術來對抗植體周圍炎，顯著增強骨整合並減少併發症。一分鐘的紫外線治療可去除鈦植體中的碳氫化合物，促進更快的癒合並限制細菌入侵，旨在根除植體周圍炎。

目錄

第1章：植體周圍炎治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的植體周圍炎治療市場片段
    • 按治療類型分類的植體周圍炎治療市場片段
    • 植體周圍炎治療市場片段（依作用機轉）
    • 最終用戶的植體周圍炎治療市場片段
    • 按國家/地區分類的植體周圍炎治療市場片段
    • 按地區分類的植體周圍炎治療市場片段
  • 競爭洞察

第 3 章：植體周圍炎治療主要市場趨勢

  • 植體周圍炎治療市場促進因素
    • 市場促進因素的影響分析
  • 植體周圍炎治療市場限制
    • 市場限制影響分析
  • 植體周圍炎治療市場機會
  • 植體周圍炎治療市場未來趨勢

第 4 章：植體周圍炎治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：植體周圍炎治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：植體周圍炎治療市場格局

  • 2023 年植體周圍炎治療市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：植體周圍炎治療市場 - 依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 抗生素
    • 防腐劑
    • 骨移植
    • 再生材料

第 8 章：植體周圍炎治療市場 - 依治療類型

  • 概述
    • 按治療類型分類的細分市場佔有率分析
    • 非手術治療
    • 手術治療

第 9 章：植體周圍炎治療市場 - 依作用機制

  • 概述
    • 按作用機制分類的細分市場佔有率分析
    • 在地化交付
    • 系統性交付

第 10 章：植體周圍炎治療市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 牙醫診所
    • 醫院
    • 研究實驗室

第 11 章：植體周圍炎治療市場 - 依地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美植體周圍炎治療主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按治療類型）
    • 北美市場規模與預測（按作用機制）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲植體周圍炎治療主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按治療類型）
    • 歐洲市場規模與預測（按作用機制）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區植體周圍炎治療主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（按治療類型）
    • 亞太地區市場規模與預測（按作用機制）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲植體周圍炎治療主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按治療類型）
    • 拉丁美洲市場規模與預測（按作用機制）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲植體周圍炎治療主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按治療類型）
    • 中東和非洲市場規模和預測（按作用機制）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 植體周圍炎治療產業

  • 競爭儀表板
  • 公司簡介
    • Bicon, LLC
    • BioHorizons IPH, Inc.
    • Camlog Biotechnologies AG
    • Corus Medical, Inc.
    • Dentium Co., Ltd.
    • Dentsply Sirona Inc.
    • Henry Schein, Inc.
    • Hiossen, Inc.
    • Implant Direct Sybron International
    • Keystone Dental, Inc.
    • Megagen Implant Co., Ltd.
    • Nobel Biocare Services AG
    • Osstem Implant Co., Ltd.
    • Straumann Holding AG
    • TBR Implants
    • Zimmer Biomet Holdings, Inc.
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4005

REPORT HIGHLIGHT

Peri-Implantitis Treatment Market size was valued at USD 2,480.43 Million in 2023, expanding at a CAGR of 8.90% from 2024 to 2032.

The peri-implantitis treatment market focuses on addressing inflammation and bone loss around dental implants, affecting a significant portion of the population, with studies indicating that up to 30% of implant patients experience peri-implantitis at some point. Factors such as the increasing prevalence of dental implants, the rising geriatric population, and advancements in dental technologies are propelling market growth. However, challenges such as high treatment costs and limited patient awareness may restrain market expansion. Opportunities lie in the development of innovative treatment modalities, such as laser therapy and biomaterials for enhanced healing. Additionally, educational initiatives aimed at dental professionals and patients can further drive awareness and treatment adoption, ensuring better outcomes for those affected by this condition. Organizations like the American Academy of Periodontology emphasize the importance of peri-implant health, further supporting the need for effective treatment solutions.

Peri-Implantitis Treatment Market- Market Dynamics

Increasing Geriatric Population Fuels Demand in the Peri-Implantitis Treatment Market

The rising geriatric population is significantly boosting demand in the peri-implantitis treatment market, as older adults are more prone to dental complications, including implant failures. According to the World Health Organization, the global population aged 60 and older is projected to reach 2 billion by 2050, leading to a heightened need for effective dental care solutions. Moreover, studies have shown that peri-implantitis affects nearly 10-20% of implant patients, underscoring the necessity for targeted treatments. Initiatives from organizations like the American Academy of Periodontology are focusing on educating healthcare professionals about prevention and treatment options, further driving market growth. With increasing awareness and the adoption of advanced therapeutic methods, the peri-implantitis treatment sector is well-positioned to meet the evolving needs of an aging population, highlighting the critical intersection of demographic trends and healthcare innovation.

Peri-Implantitis Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2024-2032)

Based on product type segmentation, antibiotics were predicted to show maximum market share in the year 2023

Based on Treatment Type segmentation, Non-Surgical Treatments was the leading type in 2023

Based on Mechanism of Action segmentation, Localized Delivery was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Peri-Implantitis Treatment Market- Segmentation Analysis:

The Global Peri-Implantitis Treatment Market is segmented on the basis of Product Type, Treatment Type, Mechanism of Action, End-User, and Region.

The market is divided into four categories based on product type: Antibiotics, Antiseptics, Bone Grafts, and Regenerative Materials. Antibiotics are prioritized due to their effectiveness in managing infections, followed by antiseptics that help in reducing microbial load. Bone grafts play a crucial role in restoring bone integrity, while regenerative materials support tissue healing and regeneration.

The market is divided into two categories based on Treatment Type: Non-Surgical Treatments and Surgical Treatments. Non-surgical treatments are prioritized for their minimally invasive nature and effectiveness in early stages, while surgical treatments are essential for advanced cases requiring more extensive intervention to restore implant health and function.

Peri-Implantitis Treatment Market- Geographical Insights

The peri-implantitis treatment market exhibits significant regional variations, with North America emerging as a leading region due to its advanced healthcare infrastructure and high adoption rates of dental implants. The American Dental Association highlights that nearly 3 million people in the U.S. have dental implants, increasing the need for peri-implantitis treatments. Europe follows closely, where countries like Germany and the UK invest in advanced dental technologies and research initiatives aimed at improving implant outcomes. In Asia-Pacific, rapid urbanization and rising disposable incomes are driving the demand for dental implants and associated treatments, with a notable increase in dental tourism in countries like Thailand and India. Meanwhile, the Middle East and Africa are gradually increasing awareness and accessibility to dental care, as initiatives focus on improving healthcare infrastructure. As global collaborations and research expand, the treatment landscape for peri-implantitis is set to evolve, addressing the unique challenges faced in different regions while promoting better oral health practices worldwide.

Peri-Implantitis Treatment Market- Competitive Landscape:

In the competitive landscape of the peri-implantitis treatment market, North America stands out as a dominant region, driven by key players such as Zimmer Biomet and Dentsply Sirona, who are at the forefront of innovative treatment solutions. The American Academy of Periodontology has reported that approximately 10% to 20% of dental implant patients experience peri-implantitis, spurring growth in advanced therapies. Europe follows closely, with companies like Straumann and BioHorizons leading the charge, supported by rigorous clinical studies to enhance treatment efficacy. In Asia-Pacific, growing awareness of oral health and increasing dental implant adoption are fostering market growth, with regional players like Osstem Implant gaining traction. The Middle East and Africa are witnessing a rise in dental healthcare investments, with local initiatives focusing on improving access to quality peri-implantitis treatments. Overall, the competitive landscape is characterized by a mix of established players and emerging companies, all striving to address the increasing demand for effective peri-implantitis management solutions globally.

Recent Developments:

In November 2023, UCLA researchers developed a groundbreaking UV light technology to combat peri-implantitis, significantly enhancing osseointegration and reducing complications. The one-minute UV treatment removes hydrocarbons from titanium implants, promoting faster healing and limiting bacterial invasion, aiming to eradicate peri-implantitis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Bicon, LLC
  • BioHorizons IPH, Inc.
  • Camlog Biotechnologies AG
  • Corus Medical, Inc.
  • Dentium Co., Ltd.
  • Dentsply Sirona Inc.
  • Henry Schein, Inc.
  • Hiossen, Inc.
  • Implant Direct Sybron International
  • Keystone Dental, Inc.
  • Megagen Implant Co., Ltd.
  • Nobel Biocare Services AG
  • Osstem Implant Co., Ltd.
  • Straumann Holding AG
  • TBR Implants
  • Zimmer Biomet Holdings, Inc.
  • Others

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Antibiotics
  • Antiseptics
  • Bone Grafts
  • Regenerative Materials

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Non-Surgical Treatments
  • Surgical Treatments

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY MECHANISM OF ACTION- MARKET ANALYSIS, 2019 - 2032

  • Localized Delivery
  • Systemic Delivery

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Dental Clinics
  • Hospitals
  • Research Laboratories

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Peri-Implantitis Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Peri-Implantitis Treatment Market Snippet by Product Type
    • 2.1.2. Peri-Implantitis Treatment Market Snippet by Treatment Type
    • 2.1.3. Peri-Implantitis Treatment Market Snippet by Mechanism of Action
    • 2.1.4. Peri-Implantitis Treatment Market Snippet by End-User
    • 2.1.5. Peri-Implantitis Treatment Market Snippet by Country
    • 2.1.6. Peri-Implantitis Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Peri-Implantitis Treatment Key Market Trends

  • 3.1. Peri-Implantitis Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Peri-Implantitis Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Peri-Implantitis Treatment Market Opportunities
  • 3.4. Peri-Implantitis Treatment Market Future Trends

4. Peri-Implantitis Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Peri-Implantitis Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Peri-Implantitis Treatment Market Landscape

  • 6.1. Peri-Implantitis Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Peri-Implantitis Treatment Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Antibiotics
    • 7.1.3. Antiseptics
    • 7.1.4. Bone Grafts
    • 7.1.5. Regenerative Materials

8. Peri-Implantitis Treatment Market - By Treatment Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment Type, 2023 & 2032 (%)
    • 8.1.2. Non-Surgical Treatments
    • 8.1.3. Surgical Treatments

9. Peri-Implantitis Treatment Market - By Mechanism of Action

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Mechanism of Action, 2023 & 2032 (%)
    • 9.1.2. Localized Delivery
    • 9.1.3. Systemic Delivery

10. Peri-Implantitis Treatment Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Dental Clinics
    • 10.1.3. Hospitals
    • 10.1.4. Research Laboratories

11. Peri-Implantitis Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Peri-Implantitis Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Peri-Implantitis Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Peri-Implantitis Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Peri-Implantitis Treatment Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Peri-Implantitis Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Peri-Implantitis Treatment Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Bicon, LLC
    • 12.2.2. BioHorizons IPH, Inc.
    • 12.2.3. Camlog Biotechnologies AG
    • 12.2.4. Corus Medical, Inc.
    • 12.2.5. Dentium Co., Ltd.
    • 12.2.6. Dentsply Sirona Inc.
    • 12.2.7. Henry Schein, Inc.
    • 12.2.8. Hiossen, Inc.
    • 12.2.9. Implant Direct Sybron International
    • 12.2.10. Keystone Dental, Inc.
    • 12.2.11. Megagen Implant Co., Ltd.
    • 12.2.12. Nobel Biocare Services AG
    • 12.2.13. Osstem Implant Co., Ltd.
    • 12.2.14. Straumann Holding AG
    • 12.2.15. TBR Implants
    • 12.2.16. Zimmer Biomet Holdings, Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us